Market News - US stock indices collectively rose, with the Dow Jones up 740.58 points (1.78%), Nasdaq up 2.47%, and S&P 500 up 2.05%. Major tech stocks saw gains, with Tesla rising nearly 7% and Nvidia over 3%. Rocket Pharma's stock fell over 62% [1] - International gold prices dropped significantly, with spot gold falling 1.25% to $3300.46 per ounce, and COMEX gold futures down 1.27% to $3299.70 per ounce. International oil prices also weakened, with WTI crude down 0.75% to $61.07 per barrel and Brent crude down 0.56% to $63.76 per barrel [1] - European stock indices had mixed results, with Germany's DAX up 0.83% to 24226.49 points, France's CAC40 down 0.02% to 7826.79 points, and the UK's FTSE 100 up 0.69% to 8778.05 points [1] Industry Insights - The Ministry of Industry and Information Technology, National Development and Reform Commission, and National Bureau of Statistics issued a plan for the digital transformation of the electronic information manufacturing industry, aiming for over 85% CNC rate in key processes by 2027. The market size for digital transformation in China's manufacturing industry is expected to reach 1.55 trillion yuan in 2024 and 1.76 trillion yuan in 2025, with a steady growth rate of around 14% over the next five years [2] - Shanghai's Development and Reform Commission released a three-year action plan to accelerate the development of the rehabilitation assistive devices industry, encouraging investment and the inclusion of AI-enabled products in the high-quality development support range. The integration of exoskeleton therapy into medical insurance has reduced patient costs by over 60% [3] - Huawei launched the Ascend Supernode technology, which provides up to 300 PFLOPs of dense BF16 computing power, nearly double that of Nvidia's GB200 NVL72 system. This technology enhances GPU cluster efficiency and is expected to drive the domestic server industry growth [4][5]

Core Viewpoint - Shanghai is accelerating the development of the rehabilitation assistive devices industry through a three-year action plan, focusing on integrating advanced technologies such as artificial intelligence, smart sensing, information communication, and brain-computer interfaces into this field [1] Group 1: Policy and Support - The Shanghai Municipal Development and Reform Commission, along with other departments, has issued a three-year action plan (2025-2027) to promote the rehabilitation assistive devices industry [1] - The plan emphasizes the importance of technological breakthroughs and encourages local enterprises to apply for national-level projects related to key products such as nursing robots, rehabilitation robots, bionic prosthetics, wearable devices, and virtual reality rehabilitation training equipment [1] Group 2: Goals and Targets - By 2027, the plan aims to implement 10 key technology (product) research and development projects and support more than 5 products under the elderly care technology special support [1]

Core Viewpoint - The establishment of the "Key Laboratory of Rehabilitation Aids" by the Ministry of Civil Affairs marks a significant milestone for the rehabilitation aids industry in Shenzhen, aiming to overcome technological bottlenecks and promote the intelligent and precise upgrade of domestic rehabilitation aids [1][2][3] Group 1 - The laboratory will focus on three main directions: the development of intelligent rehabilitation aids, technology for reconstructing motor functions, and personalized adaptation of aids [1][2] - Key technological breakthroughs will include advancements in 3D printing lightweight biomaterials, precision transmission, intelligent sensing, and AI motion analysis algorithms [1][2] - The laboratory aims to create China's first standard database for the adaptation of rehabilitation aids based on sports injury recovery through real-time data collection from multi-modal sensors [1][3] Group 2 - The laboratory's establishment is part of a broader initiative to develop a comprehensive sports medicine and rehabilitation center in Shenzhen, integrating research, clinical practice, and public health [2][3] - Shenzhen is one of the first 12 comprehensive innovation pilot areas for rehabilitation aids in China, leveraging its industrial cluster advantages to enhance the development of key technologies [3] - The laboratory will facilitate collaboration between medical and engineering sectors, accelerating the full-chain ecosystem of clinical needs, research innovation, and industrial application [3]